Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT).

导出原文传递

翻译打印收藏纠错

第一作者： Xianhui,Qin

第一单位： National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

作者： Xianhui,Qin ^[1] ; Youbao,Li ^[1] ; Mingli,He ^[2] ; Genfu,Tang ^[3] ; Delu,Yin ^[4] ; Min,Liang ^[5] ; Binyan,Wang ^[1] ; Jing,Nie ^[1] ; Yong,Huo ^[1] ; Xin,Xu ^[6] ; Fan Fan,Hou ^[1]

作者单位： National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. ^[1] Departments of Neurology and. ^[2] Institute for Biomedicine and. ^[3] School of Health Administration, Anhui Medical University, Hefei, China; and. ^[4] Cardiology, First People's Hospital, Lianyungang, China. ^[5] Department of Cardiology, Peking University First Hospital, Beijing, China. ^[6] National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China; ffhouguangzhou@163.com. ^[7]

关键词 controlled hyperuricemia folic acid supplementation new-onset hyperuricemia total homocysteine uric acid concentrations